Yes Bank To Approve JC Flowers' Purchase Of Its $6 billion Stressed Loan Portfolio: Report
Indian lender Yes Bank is likely to approve the transfer of stressed assets worth Rs 480 billion ($6 billion) to private equity firm JC Flowers at its next board meeting, said a source with direct knowledge.
A rival consortium led by private equity firm Cerberus and Asset Reconstruction Company of India withdrew its bid after submitting an expression of interest earlier this year, two sources said.
"We evaluated the loan accounts carefully and realised that there were so many fraud-hit and other problematic accounts that recovery would have been a challenge," said the second source.
J.C. Flowers had submitted an initial bid of 111.83 billion rupees for the entire stressed loan portfolio of 480 billion rupees. The Cerberus-ARCIL consortium was supposed to submit a competing bid by Sept. 7 but they withdrew, the sources said.
"Once the board approves the J.C. Flowers bid, it will take about a month for the paperwork to be completed and the assets to be transferred," the first source said.
Yes Bank, J.C. Flowers, Cerberus and ARCIL did not immediately respond to an email request seeking comment.
Lender Yes Bank believes that its gross bad loans can come down to 2% from 13.4% in June quarter after transferring the bad loans to the new asset reconstruction company, it said earlier.
The bank had already provisioned for over 80% of the total loan value which will now be transferred to J.C. Flowers.
The transfer of stressed loans away from its book is a crucial step for Yes Bank and comes more than two years after the central bank had to step in to take control of the bank after a dramatic rise in toxic assets alarmed investors and depositors, posing a systemic risk to India's banking sector.
The lender raised capital worth $1.1 billion by selling up to a 10% stake to Carlyle Group and Advent International in August. The confidence capital has also helped its stock rise up by nearly 40% since June 30.
($1 = 79.5925 Indian rupees)
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.